Full Text
Egfr Test-Guided Erlotinib Versus Chemotherapy For First-Line Treatment Of Advanced Non-Small Cell Lung Cancer- A Budget Impact Analysis

Abstract

Authors

P.S. Bajaj J.J. Carlson H.P. Goertz D.L. Veenstra

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×